Modulating the metabolism by trimetazidine enhances myoblast differentiation and promotes myogenesis in cachectic tumor-bearing c26 mice

Trimetazidine (TMZ) is a metabolic reprogramming agent able to partially inhibit mitochondrial free fatty acid β-oxidation while enhancing glucose oxidation. Here we have found that the metabolic shift driven by TMZ enhances the myogenic potential of skeletal muscle progenitor cells leading to MyoD,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Gatta, Lucia, Vitiello, Laura, Gorini, Stefania, Chiandotto, Sergio, Costelli, Paola, Giammarioli, Anna Maria, Malorni, Walter, Rosano, Giuseppe, Ferraro, Elisabetta
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2017
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5768376/
https://ncbi.nlm.nih.gov/pubmed/29371959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23044
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller